Status:
UNKNOWN
To Assess the Impact of theERAS Consensus on Patients With Endoscopic Pituitary Tumor Surgery
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Enhanced Recovery After Surgery
Pituitary Tumor
Eligibility:
All Genders
20-75 years
Brief Summary
The goal of this observational study is to evaluate the effectiveness and impact of Enhanced Recovery After Surgery (ERAS) on patients with pituitary gland tumors.
Detailed Description
The goal of this observational study is to evaluate the effectiveness and impact of Enhanced Recovery After Surgery (ERAS) on patients with pituitary gland tumors. This study is particularly significa...
Eligibility Criteria
Inclusion
- Clinical diagnosis of pituitary tumors
- To sign a written informed consent form
Exclusion
- Diagnosed with other malignant tumors
- Severe infections, such as osteomyelitis, acute inflammation at the affected site, or open wounds at the treatment area
- Pregnant women
- Coagulation disorders or those taking anticoagulant medication
- Other central nervous system disorders, alcohol addiction, other addictive drugs, or mental illness that may affect clinical assessment
- Deemed unsuitable for surgical treatment or unable to comply with clinical evaluation upon assessment
Key Trial Info
Start Date :
December 12 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2025
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06221020
Start Date
December 12 2023
End Date
November 30 2025
Last Update
January 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, Taiwan, 807